Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an
increasing number of publications have dealt with multiple aspects of SMZL diagnosis …

This review addresses the biology and the treatment of lymphomas arising from mucosa-
associated lymphoid tissue (MALT). This entity, first described in 1983, represents about 8 …

The recognition of several new types of non-Hodgkin's lymphoma (NHL) in recent years has
led to proposals for changing lymphoma classifications, including a new proposal put forth …

We conducted a retrospective collaborative study to cytogenetically characterize splenic
marginal zone lymphoma (SMZL) and ascertain the prognostic value of chromosomal …

Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue (MALT)
type occur in a number of anatomic sites, but share overlapping morphologic and …

Recently a new classification of primary cutaneous B-cell lymphomas (PCBCLs) has been
proposed by the European Organization for Research and Treatment of Cancer (EORTC) …

Summary In the World Health Organization classification system, splenic marginal-zone
lymphoma (splenic MZL) is described as an indolent B-cell lymphoma, which generally …

Splenic marginal zone lymphoma (SMZL) is a specific low-grade small B-cell lymphoma that
is incorporated in the World Health Organization classification. Characteristic features are …

The MALT1 gene was identified through its involvement in t (11; 18)(q21; q21), seen in 30%
of cases of mucosa-associated lymphoid tissue (MALT) lymphoma. Here, we show that …

This study aimed to correlate the frequency of somatic mutations in the IgVH gene and the
use of specific segments in the VH repertoire with the clinical and characteristic features of a …